Faculty profile

Shaun Goodman

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Shaun Goodman

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
156 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2023.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

793

Publications

45,909

Citations

257

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Cardiovascular Disease Beta-Blockers Myocardial Infarction Pragmatic Clinical Trial Stable Ischemic Heart Disease

Latest papers

Clinical Pharmacology of Heart Failure in Frailty
European Cardiology Review · 2026
Relation of lipoprotein(a) levels with risk of serious bleeding in the ODYSSEY OUTCOMES trial
European Journal of Preventive Cardiology · 2026
The β-Blocker Breakup: Individualizing the AβYSS of Deprescription.
Circulation · 2026 · senior author

All 793 publications

Latest funding

Lipoprotein(a) utilization, ancestry, and adverse cardiovascular and renal outcomes: a population-based cohort study
CIHR · 2026 · Co-investigator
$550,800
Sodium Glucose Co-transporter-2 Inhibition (SGLT2i) to Prevent Earliest Events of Heart Failure (SOLVE-HF): A Pilot RCT
CIHR · 2025 · Co-investigator
$1,315,801
Post-Acute Coronary Syndrome Secondary Prevention Pathway Planning Meeting: Exploring the Potential for Scale and Spread Across Canada
CIHR · 2024 · Co-investigator
$19,870

All 17 grants and awards

From the 150 most recent of 793 publications.

Clinical Pharmacology of Heart Failure in Frailty

Mai H. Duong, Martha Gulati, Parag Goyal, Shaun G. Goodman, Julee McDonagh, Sarah Nicole Hilmer

European Cardiology Review20261 citationsOpen Access

DOI: 10.15420/ecr.2025.42 PMID: 42488772

Relation of lipoprotein(a) levels with risk of serious bleeding in the ODYSSEY OUTCOMES trial

Philippe Gabríel Steg, Michael J. Szarek, Vera Bittner, Deepak L. Bhatt, Rafael Ugarriza Díaz, Shaun G. Goodman, Robert A. Harrington, Ghada Hassan, J. Wouter Jukema, Irena Stevanovic, Hagai Tavori, Samantha Thielen, Harvey Douglas White, Gregory G. Schwartz

European Journal of Preventive Cardiology2026

DOI: 10.1093/eurjpc/zwag437 PMID: 42669030

The β-Blocker Breakup: Individualizing the AβYSS of Deprescription.

van Diepen S, Goodman SG

Circulation2026Senior author

DOI: 10.1161/circulationaha.126.079321 PMID: 42766687

Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome

Gregory G. Schwartz, Michael J. Szarek, Vera Bittner, Deepak L. Bhatt, Rafael Dı́az, Shaun G. Goodman, Robert A. Harrington, Ghada Hassan, J. Wouter Jukema, Irena Stevanovic, Hagai Tavori, Samantha Thielen, Harvey Douglas White, Philippe Gabríel Steg

American Journal of Preventive Cardiology2026Open Access

DOI: 10.1016/j.ajpc.2026.101747

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Ghafghazi S, Uhl L, Herbert B, Bertolet M, Alexander JH, Goodman SG, Raval J, Roubille F, Fordyce CB, Goldfarb M, Bainey K, de Andrade PB, Senaratne J, Bracey A, Roswell RO, Lopes R, Simon T, Steg G, Brooks MM, Hebert PC, Carson JL, Triulizi DJ, MINT Trial Investigators

Transfusion2026Open Access

DOI: 10.1111/trf.70006 PMID: 41305907

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism

Capodanno D, Alexander JH, Bahit MC, Eikelboom JW, Gibson CM, Goodman SG, Kunadian V, Lip GYH, Lopes RD, Mehran R

Nature Reviews Cardiology202546 citations

DOI: 10.1038/s41569-025-01144-z

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

Philippe Gabríel Steg, Michael J. Szarek, J. Wouter Jukema, Deepak L. Bhatt, Vera Bittner, Rafael Ugarriza Díaz, Sergio Fazio, Geneviève Garon, Shaun G. Goodman, Robert A. Harrington, Harvey Douglas White, Andreas Michael Zeiher, Gregory G. Schwartz, Gregory G. Schwartz, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Ugarriza Díaz, Shaun G. Goodman, Robert A. Harrington, J. Wouter Jukema, Michael J. Szarek, Harvey Douglas White, Andreas Michael Zeiher, Pierluigi Tricoci, Matthew T. Roe, Kenneth W. Mahaffey, Jay M. Edelberg, Corinne Hanotin, Guillaume Lecorps, et al. (1693 authors)

Circulation202525 citationsOpen Access

DOI: 10.1161/circulationaha.124.071269 PMID: 40193536

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

Al Said S, Patel SM, Giugliano RP, Morrow DA, Goodrich EL, Murphy SA, Hug B, Parkar S, Chen S-A, Goodman SG

Circulation202516 citations

DOI: 10.1161/circulationaha.125.074037

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial

Gregory G. Schwartz, Michael J. Szarek, J. Wouter Jukema, Christa M. Cobbaert, Esther Reijnders, Vera Bittner, Markus Schwertfeger, Deepak L. Bhatt, Sergio Fazio, Geneviève Garon, Shaun G. Goodman, Robert A. Harrington, Harvey Douglas White, Philippe Gabríel Steg

Diabetes Care202511 citationsOpen Access

DOI: 10.2337/dc24-2110 PMID: 39913634

Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINT.

Goldsweig AM, Kostis WJ, Herbert BM, Bouleti C, Potter BJ, Strom JB, Benatar J, Huynh T, Vallurupalli S, Figueiredo EL, Abbott JD, Cooper HA, DeFilippis AP, Fergusson DA, Goodman SG, Hébert PC, Lopes RD, Rao SV, Simon T, Carson JL, Brooks MM, Alexander JH, MINT Investigators

Circulation. Heart failure20259 citationsOpen Access

DOI: 10.1161/circheartfailure.124.012495 PMID: 40135329

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Shaun Goodman

Research

Latest papers

Latest funding

Clinical Pharmacology of Heart Failure in Frailty

Relation of lipoprotein(a) levels with risk of serious bleeding in the ODYSSEY OUTCOMES trial

The &#x3b2;-Blocker Breakup: Individualizing the A&#x3b2;YSS of Deprescription.

Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial

Blood Transfusion in Patients With Acute Myocardial Infarction, Anemia, and Heart Failure: Lessons From MINT.

Frequent collaborators

Shamir Mehta

Jacob Udell

Michael Farkouh

Anatoly Langer

Lawrence Leiter

Thao Huynh

Akshay Bagai

Dennis Ko

Derek So

Paul Dorian

Shahar Lavi

Michael Heffernan

Derek Chew

Sean Van Diepen

Frederick Spencer

Nigel Tan

Hwee Teoh

Padma Kaul

Douglas Lee

Justin Ezekowitz

Peter Austin

Anil Gupta

Gilbert Gosselin

Adriana Luk

Keyur Patel

Iqwal Mangat

Milan Gupta

Maral Ouzounian

Christian Constance

John Graham

André-Guy Martin

Ilana Saltzman

Stephanie Poon

Hanna Lee

Giridhar Logsetty

Alexander Kiss

Christopher Morgan

The β-Blocker Breakup: Individualizing the AβYSS of Deprescription.